Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUSP3 | P51452 | 1/20 | 1.00 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ME2 | P23368 | 1/20 | 0.37 |
| ▸ | ME1 | P48163 | 1/20 | 0.37 |
| ▸ | ME3 | Q16798 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16309126 | 0.81 | DUSP3 (0.68) | DUSP3MAPTKDM4EHSD17B10TP53 | |
| SCHEMBL7287351 | 0.81 | DUSP3 (0.68) | DUSP3MAPTKDM4EHSD17B10TP53 | |
| SCHEMBL10609498 | 0.74 | DUSP3 (0.58) | DUSP3MAPTKDM4EHSD17B10TP53 | |
| SCHEMBL9175310 | 0.69 | DUSP3 (0.52) | DUSP3MAPTKDM4EHSD17B10TP53 | |
| SCHEMBL33978 | 0.69 | DUSP3 (0.52) | DUSP3MAPTKDM4EHSD17B10TP53 | |
| SCHEMBL16080094 | 0.67 | — | — | |
| SCHEMBL9180312 | 0.65 | DUSP3 (0.48) | DUSP3MAPTKDM4EHSD17B10TP53 | |
| SCHEMBL10035859 | 0.65 | — | — | |
| SCHEMBL12156967 | 0.65 | — | — | |
| SCHEMBL112795 | 0.64 | APAF1 (0.68) | DUSP3MAPTKDM4EMAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102511-A1 | ENGINEERED FUNGI HAVING INCREASED VIRULENCE AND METHODS OF USING THE SAME | EMPRESA BRASILEIRA DE PESQUISA AGROPECUÁRIA - EMBRAPA (BR) | 2026-05-21 | — | — | WO | claimed |
| CN-120154021-A | Antibacterial active substance and application thereof | 西北农林科技大学深圳研究院 | 2025-06-17 | — | — | CN | claimed |
| CN-116121083-B | Beauveria bassiana strain as a spawning sporulation and application thereof in synthesis of oosporine in CZB | 西南大学 | 2024-06-25 | — | — | CN | claimed |
| CN-117004660-A | Antarctic silicon algae bacteriocin amino acid and induced expression, extraction method and application thereof | 自然资源部第一海洋研究所 | 2023-11-07 | — | — | CN | claimed |
| CN-116121083-A | Beauveria bassiana strain as a spawning sporulation and application thereof in synthesis of oosporine in CZB | 西南大学 | 2023-05-16 | — | — | CN | claimed |
| CN-108486180-A | A kind of fermentation preparation of oosporein | 中国科学院成都生物研究所 | 2018-09-04 | — | — | CN | claimed |
| CN-107652173-A | A kind of method that oosporein is extracted in the cupreum zymotic fluid from angle | 中国科学院成都生物研究所 | 2018-02-02 | — | — | CN | claimed |
| CN-106942224-A | Application of the oosporein in biological pesticide is prepared | 广东省微生物研究所（广东省微生物分析检测中心） | 2017-07-14 | — | — | CN | claimed |
| CN-105985967-A | Biosynthetic gene cluster of oosporein and application of biosynthetic gene cluster | 中国科学院上海生命科学研究院 | 2016-10-05 | — | — | CN | claimed |
| CN-105441332-A | Beauveria bassiana separated from tussah and application of beauveria bassiana | UNIV DALIAN TECH | 2016-03-30 | — | — | CN | claimed |
| US-20100178300-A1 | CLAY INTERLACED YEAST COMPOSITIONS AND METHODS OF UTILIZING THE SAME | ALLTECH, INC. (US) | 2010-07-15 | — | — | US | claimed |
| JP-4370072-B2 | — | — | 2009-11-25 | — | — | JP | claimed |
| US-20070191330-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | PROTEOTECH, INC. | 2007-08-16 | — | — | US | claimed |
| EP-1808169-A2 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | Proteotech Inc. (US) | 2007-07-18 | — | — | EP | claimed |
| US-20070110726-A1 | Rust disease control by Aphanocladium album and/or Beauveria brongniartii | PHYTOMYCO RESEARCH CORPORATION (US) | 2007-05-17 | — | — | US | claimed |
| US-20040152760-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | PROTAMED, INC. | 2004-08-05 | — | — | US | claimed |
| JP-2003532634-A | — | — | 2003-11-05 | — | — | JP | claimed |
| EP-1244435-A2 | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND $g(a)-SYNUCLEIN FIBRIL DISEASES | Proteotech Inc. (US) | 2002-10-02 | — | — | EP | claimed |
| US-20010047032-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | PROTAMED, INC. | 2001-11-29 | — | — | US | claimed |
| WO-2001049281-A2 | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND α-SYNUCLEIN FIBRIL DISEASES | PROTEOTECH, INC. (US) | 2001-07-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070110726-A1 | Rust disease control by Aphanocladium album and/or Beauveria brongniartii | ERG28, HLA-A, GET3 | DUSP3 2144/4885SENP1 1491/4885MAPT 216/4885 |
| US-20070191330-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | SNCA, PARK7, HTT | DUSP3 3687/4885SENP1 1261/4885MAPT 4/4885 |
| US-20010047032-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | SNCA, PARK7, HTT | DUSP3 3808/4885SENP1 1271/4885MAPT 4/4885 |
| US-20040152760-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | SNCA, PARK7, HTT | DUSP3 3808/4885SENP1 1271/4885MAPT 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.